Prime Medicine, Inc. Common Stock (PRME)
Healthcare
Biotechnology
2.80 $
-3.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Prime Medicine, Inc. Common Stock (PRME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -43 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41 | -39 | -44 | -68 | -45 | -26 | 16 | -49 | -41 | -35 | -37 | -43 | -156 | |
| 1.1 | 1.2 | 1.2 | 1.3 | 1.5 | 1.6 | 1.7 | 1.5 | 1.5 | 1.9 | 0.5 | 1.9 | 5.7 | |
| 3.6 | 4.2 | 4.4 | 5.2 | 8.1 | 6.8 | 5.9 | 5.7 | 6.3 | 13 | 4.5 | 4.6 | 28 | |
| 3.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.6 | 2.4 | 14 | -30 | 8.8 | 3.6 | 49 | -7.7 | 0.5 | 0.6 | 1.2 | -2.5 | -0.2 | |
| 2.0 | 2.9 | 1.8 | 2.3 | 1.9 | 1.3 | 1.8 | 2.4 | 1.6 | 0.2 | 0.3 | 0.2 | 2.3 | |
| 28 | -38 | 41 | -37 | 6.9 | 50 | 48 | -48 | 2.8 | -92 | 28 | 43 | -18 | |
| 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1 | 0.3 | 0.2 | 157 | 0.0 | 39 | 0.0 | 6.0 | 0.2 | 145 | 0.6 | 0.4 | 146 | |
| -13 | -77 | -2.4 | 53 | -39 | 63 | 64 | -91 | -38 | 18 | -8.4 | 1.1 | -28 | |
| -43 | -42 | -46 | -70 | -47 | -27 | 14 | -51 | -43 | -35 | -38 | -43 | -159 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.